ES2058070T3 - Utilizacion de monosacaridos especificos para la preparacion de un medicamento para impedir metastasis de tumores malignos. - Google Patents

Utilizacion de monosacaridos especificos para la preparacion de un medicamento para impedir metastasis de tumores malignos.

Info

Publication number
ES2058070T3
ES2058070T3 ES87105548T ES87105548T ES2058070T3 ES 2058070 T3 ES2058070 T3 ES 2058070T3 ES 87105548 T ES87105548 T ES 87105548T ES 87105548 T ES87105548 T ES 87105548T ES 2058070 T3 ES2058070 T3 ES 2058070T3
Authority
ES
Spain
Prior art keywords
preparation
malignant tumors
medicinal product
prevent metastasis
specific monosaccharides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87105548T
Other languages
English (en)
Inventor
Gerhard Prof Dr Dr H Pulverer
Kurt Prof Dr Med Oette
Gerd Prof Dr Med Uhlenbruck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2058070T3 publication Critical patent/ES2058070T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Solid Fuels And Fuel-Associated Substances (AREA)

Abstract

MEDIOS Y PROCEDIMIENTO PARA EVITAR LAS METASTASIS DE LOS TUMORES MALIGNOS, CON LA UTILIZACION DE MONOSACARIDOS ESPECIFICOS PARA ORGANOCELULOLECTINA, Y/O PREFERENTEMENTE LOS GLICOCONJUGADOS RESULTANTES, CONTENIENDO ESTOS MONOSACARIDOS, ESPECIALMENTE LA (BETA) OS, QUE CONTIENEN (BETA) - D - GALACTOSA.
ES87105548T 1986-05-09 1987-04-14 Utilizacion de monosacaridos especificos para la preparacion de un medicamento para impedir metastasis de tumores malignos. Expired - Lifetime ES2058070T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3615621 1986-05-09

Publications (1)

Publication Number Publication Date
ES2058070T3 true ES2058070T3 (es) 1994-11-01

Family

ID=6300445

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87105548T Expired - Lifetime ES2058070T3 (es) 1986-05-09 1987-04-14 Utilizacion de monosacaridos especificos para la preparacion de un medicamento para impedir metastasis de tumores malignos.

Country Status (6)

Country Link
US (1) US4946830A (es)
EP (1) EP0249008B1 (es)
JP (1) JPH07100658B2 (es)
AT (1) ATE94395T1 (es)
DE (1) DE3787403D1 (es)
ES (1) ES2058070T3 (es)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5490991A (en) * 1986-07-03 1996-02-13 Advanced Magnetics, Inc. Directed delivery of radioprotectants using a receptor specific carrier
US5554386A (en) * 1986-07-03 1996-09-10 Advanced Magnetics, Inc. Delivery of therapeutic agents to receptors using polysaccharides
US5679323A (en) * 1986-07-03 1997-10-21 Advanced Magnetics, Inc. Hepatocyte-specific receptor-mediated endocytosis-type compositions
EP0546122A1 (en) * 1990-08-30 1993-06-16 The Biomembrane Institute Inhibition of metastasis potential and invasiveness by oligosaccharides or oligosaccharide antigens or antibodies
KR100192862B1 (ko) * 1991-01-10 1999-06-15 슈테펜엘.네스비트 항당뇨병제로서 유용한 신규한 글루코하이드롤라제 억제제
US6121233A (en) * 1991-04-19 2000-09-19 John L. Magnani Methods for the inhibition of cancer metastasis mediated by endothelial adhesion molecules
EP0521692A3 (en) * 1991-07-02 1993-02-03 The Biomembrane Institute Inhibition of tumor cell metastasis potential and invasiveness by chemically-defined oligosaccharides, their derivatives, mimetics and antibodies directed to them
US5639737A (en) * 1991-11-04 1997-06-17 Co Enzyme Technology Ltd. Method and compositions for treating malignant tumors and inhibiting growth and metastases of malignant tumors
US5760008A (en) * 1991-11-04 1998-06-02 Co Enzyme Technology Ltd. Method and compositions for treating malignant tumors and inhibiting metastases of malignant tumors
US5376531A (en) * 1992-09-03 1994-12-27 Northwestern University Method of detecting cancer
ATE196296T1 (de) * 1992-12-16 2000-09-15 Basf Ag Dolastatin analog
GB9315846D0 (en) * 1993-07-30 1993-09-15 Isis Innovation Tumour inhibitors
US5654273A (en) * 1994-09-22 1997-08-05 Children's Medical Center Corporation Synducin mediated modulation of tissue repair
AU2003249641B2 (en) 2002-05-16 2009-08-20 Glycomimetics, Inc. Compounds and methods for inhibiting selectin-mediated function
AU2003245595A1 (en) * 2002-07-03 2004-01-23 Glycomimetics, Inc. Compositions and methods for diagnosis and therapy of medical conditions involving angiogenesis
US20040219158A1 (en) * 2003-05-02 2004-11-04 Glycomimetics, Inc. Compositions and methods for diagnosis and therapy of medical conditions involving infection with pseudomonas bacteria
EP1643969A2 (en) * 2003-07-11 2006-04-12 Pro-Pharmaceuticals, Inc. Compositions and methods for hydrophobic drug delivery
US20050053664A1 (en) * 2003-09-08 2005-03-10 Eliezer Zomer Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
AU2003271016A1 (en) * 2003-09-17 2005-04-06 Bio-Wave Institute Of Suzhou Hi-Tech New District Corporation, Ltd. Use of n-acetyl-d-aminoglycosamine in preparation of drugs for the treatment of cacer and metastasis
ATE383367T1 (de) * 2003-11-19 2008-01-15 Glycomimetics Inc Spezifischer antagonist sowohl für e- als auch p- selektine
JP2007524658A (ja) * 2003-11-19 2007-08-30 グリコミメティクス， インコーポレイテッド Ｅ−およびｐ−セレクチンの両方のための糖模倣物アンタゴニスト
WO2005079314A2 (en) * 2004-02-13 2005-09-01 Pro-Pharmaceuticals, Inc. Compositions and methods used to treat acne and candida
WO2005092097A1 (en) * 2004-03-19 2005-10-06 Pro-Pharmaceuticals, Inc. Compositions and methods for targeting metastatic tumors using multivalent ligand-linked carbohydrate polymers
US20080286251A1 (en) * 2004-08-02 2008-11-20 Propharmaceuticals, Inc. Compositions and Methods for the Enhancement of Chemotherapy with Microbial Cytotoxins
US8201377B2 (en) * 2004-11-05 2012-06-19 Faus Group, Inc. Flooring system having multiple alignment points
US20090036386A1 (en) * 2005-05-25 2009-02-05 Glycomimetics, Inc Heterobifunctional compounds for selectin inhibition
US7517980B2 (en) * 2005-08-09 2009-04-14 Glycomimetics, Inc. Glycomimetric inhibitors of the PA-IL lectin, PA-IIL lectin or both the lectins from Pseudomonas
SI2264043T1 (en) * 2005-09-02 2018-01-31 Glycomimetics, Inc. HETEROBIFUNCTIONAL PAN-SELECTINE INHIBITORS
WO2007143052A1 (en) * 2006-06-01 2007-12-13 Glycomimetics, Inc. Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonas
WO2008060378A2 (en) * 2006-10-12 2008-05-22 Glycomimetics, Inc. Glycomimetic replacements for hexoses and n-acetyl hexosamines
EP2457573A1 (en) * 2007-02-09 2012-05-30 GlycoMimetics, Inc. Methods of use of glycomimetics with replacements for hexoses and N-Acetyl hexosamines
US8039442B2 (en) 2007-07-18 2011-10-18 Glycomimetics, Inc. Compounds and methods for treatment of sickle cell disease or complications associated therewith
US8895510B2 (en) * 2008-04-08 2014-11-25 Glycomimetics, Inc. Pan-selectin inhibitor with enhanced pharmacokinetic activity
AU2009257536B2 (en) * 2008-06-13 2015-07-02 Glycomimetics, Inc. Treatment of cancers of the blood using selected glycomimetic compounds
CN102421441B (zh) * 2009-05-01 2015-04-01 糖模拟物有限公司 E-选择蛋白和cxcr4趋化因子受体的异双功能抑制剂
WO2012037034A1 (en) 2010-09-14 2012-03-22 Glycomimetics, Inc. E-selectin antagonists
JP2015500887A (ja) 2011-12-22 2015-01-08 グリコミメティクス， インコーポレイテッド Ｅ−セレクチンアンタゴニスト化合物、組成物および使用方法
HUE038423T2 (hu) 2012-12-07 2018-10-29 Glycomimetics Inc E-szelektin antagonistákat felhasználó vegyületek, készítmények és eljárások vérképzõ sejtek mobilizációjára
PT3227310T (pt) 2014-12-03 2019-11-06 Glycomimetics Inc Inibidores heterobifuncionais de e-selectinas e recetores de quimiocina cxcr4
CA3009836A1 (en) 2016-01-22 2017-07-27 Glycomimetics, Inc. Glycomimetic inhibitors of pa-il and pa-iil lectins
US11291678B2 (en) 2016-03-02 2022-04-05 Glycomimetics, Inc Methods for the treatment and/or prevention of cardiovascular disease by inhibition of E-selectin
EP3497131B1 (en) 2016-08-08 2022-03-09 GlycoMimetics, Inc. Combination of t-cell checkpoint inhibitors with inhibitors of e-selectin or cxcr4, or with heterobifunctional inhibitors of both e-selectin and cxcr4.
KR102653723B1 (ko) 2016-10-07 2024-04-01 글리코미메틱스, 인크. 매우 강력한 다량체성 e-셀렉틴 길항물질
US11197877B2 (en) 2017-03-15 2021-12-14 Glycomimetics. Inc. Galactopyranosyl-cyclohexyl derivauves as E-selectin antagonists
US11712446B2 (en) 2017-11-30 2023-08-01 Glycomimetics, Inc. Methods of mobilizing marrow infiltrating lymphocytes and uses thereof
CA3085356A1 (en) 2017-12-29 2019-07-04 Glycomimetics, Inc. Heterobifunctional inhibitors of e-selectin and galectin-3
BR112020018184A2 (pt) 2018-03-05 2021-02-02 Glycomimetics, Inc. usos de compostos
US11845771B2 (en) 2018-12-27 2023-12-19 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1158456A (en) * 1967-06-13 1969-07-16 Prodotti Antibiotici Spa Preparations Containing Sugars
US3931402A (en) * 1970-12-02 1976-01-06 Societa Prodotti Antibiotici S.P.A. Preparations containing hexoses
US4243663A (en) * 1976-06-25 1981-01-06 Ichiro Azuma Glycolipid compositions for transplanted tumor immunotherapy
ES8102679A1 (es) * 1979-01-30 1981-02-16 Otsuka Pharma Co Ltd Metodo de analizar fluidos corporales.
US4334017A (en) * 1979-04-16 1982-06-08 Massachusetts Institute Of Technology Method for detecting cancer in mammalian tissue
FI67386C (fi) * 1979-06-21 1985-03-11 Hoffmann La Roche Foerfarande foer framstaellning av nya terapeutiskt anvaendbara sockerderivat
CA1120399A (en) * 1979-09-28 1982-03-23 Universite De Sherbrooke Pharmaceutical compositions for treatment of tumor cells
GB2106935B (en) * 1981-10-01 1985-01-30 Otsuka Pharma Co Ltd Cancer cell-combatting lymphocytes process for the production thereof and anticancer agents containing said lymphocytes
DE3202894A1 (de) * 1982-01-29 1983-08-11 Otsuka Pharmaceutical Co. Ltd., Tokyo Verfahren zur bestimmung von tumor-assoziierten glykoprotein enthaltenden verbindungen, anwendung des verfahrens zur krebsdiagnose und kit fuer die anwendung des verfahrens
US4496539A (en) * 1982-02-01 1985-01-29 Massachusetts Institute Of Technology Method for treating cancer using galactose-specific lectins
IT1168205B (it) * 1983-07-21 1987-05-20 Wellcome Italia Derivato di monsialo ganglioside dotato di attivita' antibatterica, antifungina ed antitumorale, composizioni che lo contengono e procedimento per la loro preparazione
JPS60190791A (ja) * 1984-03-09 1985-09-28 Kanto Ishi Pharma Co Ltd シアル酸誘導体およびその製造法
JPS60214737A (ja) * 1984-04-06 1985-10-28 Nippon Koutai Kenkyusho:Kk 糖鎖関連抗原の製造法
US4742046A (en) * 1984-08-03 1988-05-03 Medisearch S.A. Methods and compositions for inhibiting the infectious activity of viruses
JPS6183125A (ja) * 1984-09-28 1986-04-26 Kanto Ishi Pharma Co Ltd 癌転移阻害剤
US4656159A (en) * 1984-10-31 1987-04-07 Georgetown University Galactose-C-6 nitrogen mustard compounds and their uses

Also Published As

Publication number Publication date
JPS62267234A (ja) 1987-11-19
EP0249008A3 (en) 1989-09-27
ATE94395T1 (de) 1993-10-15
JPH07100658B2 (ja) 1995-11-01
US4946830A (en) 1990-08-07
DE3787403D1 (de) 1993-10-21
EP0249008B1 (de) 1993-09-15
EP0249008A2 (de) 1987-12-16

Similar Documents

Publication Publication Date Title
ES2058070T3 (es) Utilizacion de monosacaridos especificos para la preparacion de un medicamento para impedir metastasis de tumores malignos.
ES518784A0 (es) Perfeccionamientos introducidos en la fabricacion y estructura de bolsas-recipiente conservantes para fines medicos y similares.
AR240461A1 (es) Procedimietno para la preparacion de olisacaridos mediante la despolizacion quimica de polisacaridos naturales.
MX9203364A (es) Anticuerpos que tienen reactividad inmunologica especifica con celulas de carcinoma humano y composiciones farmaceuticas que los contienen.
IT7928199A0 (it) Composizione esplosiva del tipo in emulsione e metodo per la sua preparazione.
NL192917B (nl) Stabiele farmaceutische bereiding die granulocytkolonie-stimulerende factor bevat.
JPS5791915A (en) Novel lipid composition useful for dietetics, resuscitation and treatment
NO163986C (no) Fremgangsmaate for in vitro bedoemmelse av muligheten for cellekreft.
TR28752A (tr) Tütün yapraklarinin islenmesi ile ilgili islahat.
NL188905C (nl) Anthracyclineverbinding en farmaceutisch preparaat.
ZA83403B (en) Phenylethylene derivatives,their preparation and their use as drugs
NL187443C (nl) Antracyclineglycoside en farmaceutisch preparaat.
DE3266442D1 (en) Phenylethylene derivatives, their preparation and use as medicines
IT1117788B (it) Composizione dietetica ipo-beta-lipoproteica e procedimento per la sua preparazione
ES505321A0 (es) Procedimiento para la desintegracion de derivados de 6-amino-5-triacina,contenidos en aguas residuales
IT8123056A0 (it) Preparato cosmetico e procedimento per la sua preparazione.
IT7968842A0 (it) Procedimento per la preparazione in serie di carte d identita e o carte di credito
IT1216139B (it) Composizione dietetica eprocedimento per la sua preparazione.
GB2098478B (en) Propioibacteria preparations for use in the treatment of tumours
ES523528A0 (es) "mejoras en la preparacion de compuestos de adicion entre menadiona y tiamina".
IT8026717A0 (it) Prodotto disinfestante eprocedimento per la sua preparazione.
ZA805898B (en) Assay for the free portion of substances in biological fluids
JPS5576639A (en) Chemical substance detector in blood
ES502737A0 (es) Mejoras en la fabricacion de capsulas de medicamento
FR2529214B1 (fr) Hydrolysat de keratine, procede de preparation correspondant et composition cosmetique le contenant

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 249008

Country of ref document: ES